𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Dopa-responsive dystonia: Pathological and biochemical observations in a case

✍ Scribed by Dr. A. H. Rajput; W. R. G. Gibb; X. H. Zhong; K. S. Shannak; S. Kish; L. G. Chang; O. Hornykiewicz

Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
716 KB
Volume
35
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Novel GCH1 mutation in a Brazilian famil
Novel GCH1 mutation in a Brazilian family with dopa-responsive dystonia
✍ Sarah Teixeira Camargos; Francisco Cardoso; Parastoo Momeni; Juliana Gurgel Gian πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 78 KB

## Abstract Dopa responsive Dystonia (DRD) was first described in 1971 and typically begins at childhood with gait dysfunction caused by foot dystonia progressing to affect other extremities. There is marked diurnal fluctuation and sustained improvement of symptoms with low dose levodopa therapy. H

Neuronal intranuclear inclusion disease:
Neuronal intranuclear inclusion disease: Report on a case originally diagnosed as dopa-responsive dystonia with Lewy bodies
✍ Dominic C. Paviour; Tamas Revesz; Janice L. Holton; Andrew Evans; Jan-Edvin Olss πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 133 KB

## Abstract Neuronal intranuclear inclusion disease (NIID) is a rare neurodegenerative disorder with a heterogeneous clinical picture characterized by the presence of eosinophilic intranuclear inclusions in neuronal and glial cells. We describe a case, reported 12 years ago as dopa‐responsive dysto

Dopa-responsive dystonia and early-onset
Dopa-responsive dystonia and early-onset Parkinson's disease in a patient with GTP cyclohydrolase I deficiency?
✍ Lena Elisabeth Hjermind; Lis Gitte Johannsen; Nenad Blau; Ron Allan Wevers; Chri πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 94 KB

We describe a patient with a combination of dystonic and parkinsonian signs. Paraclinical studies revealed a mutation in the GTP cyclohydrolase I gene (GCH1) and a decrease in [ 123 I]-N--fluoropropyl-2␀-carbomethoxy-3␀-(4iodophenyl) nortropane ( 123 I-FP-CIT) binding ratios indicative of Parkinson'